Michael Halpin
Chief Operating Officer bij VERICEL CORPORATION
Vermogen: 49 367 $ op 31-03-2024
Actieve functies van Michael Halpin
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| VERICEL CORPORATION | Chief Operating Officer | 15-06-2019 | - |
| General Counsel | 10-04-2017 | 15-06-2019 |
Loopbaan van Michael Halpin
Eerdere bekende functies van Michael Halpin
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | General Counsel | 01-02-2002 | - |
| Corporate Officer/Principal | - | 01-04-2017 | |
| Sanofi Corp. | Corporate Officer/Principal | - | - |
Opleiding van Michael Halpin
| University of Virginia | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| General Counsel | 2 |
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| VERICEL CORPORATION | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| Sanofi Corp. |
- Beurs
- Insiders
- Michael Halpin
- Ervaring
